Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3681
-0.0004 (-0.11%)
At close: Jul 11, 2025, 4:00 PM
0.3698
+0.0017 (0.46%)
After-hours: Jul 11, 2025, 6:48 PM EDT
Turnstone Biologics Stock Forecast
TSBX's stock price has decreased by -84.66% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts that cover Turnstone Biologics stock have a consensus rating of "Buy" and an average price target of $4.75, which forecasts a 1190.41% increase in the stock price over the next year. The lowest target is $0.5 and the highest is $10.
Price Target: $4.75 (+1190.41%)
Analyst Consensus: Buy
* Price targets were last updated on Oct 14, 2024.
Analyst Ratings
The average analyst rating for Turnstone Biologics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $10 → $0.5 | Strong Buy → Hold | Downgrades | $10 → $0.5 | +35.83% | Oct 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +2,616.65% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $3.75 | Buy | Maintains | $20 → $3.75 | +918.74% | Aug 19, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +4,789.98% | Aug 15, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $20 | Buy | Initiates | $20 | +5,333.31% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.70
from -3.07
EPS Next Year
-0.52
from -0.70
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.72 | -0.54 |
| Avg | -0.70 | -0.52 |
| Low | -0.68 | -0.50 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.